Myeloperoxidase: A Target for New Drug Development?

British Journal of Pharmacology - United States
doi 10.1038/sj.bjp.0707358
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

Drug Development for Alzheimer’s Disease: Microglia Induced Neuroinflammation as a Target?

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2019English

A New Roadmap for Drug Development for Alzheimer's Disease

Nature Reviews Drug Discovery
MedicineDrug DiscoveryPharmacology
2013English

Tumor Necrosis Factor Receptor 2: A Potential Target for Antidepressant Drug Development

Clinical and Experimental Neuroimmunology
NeuroscienceNeurologyImmunologyMicrobiology
2019English

Tissue Transglutaminase: A New Target to Reverse Cancer Drug Resistance

Amino Acids
Organic ChemistryBiochemistryClinical Biochemistry
2011English

Myeloperoxidase: A Therapeutic Target for Preventing Insulin Resistance and the Metabolic Sequelae of Obesity?

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2014English

Cathepsin B Is a New Drug Target for Traumatic Brain Injury Therapeutics: Evidence for E64d as a Promising Lead Drug Candidate

Frontiers in Neurology
Neurology
2015English

New Treatments for Drug-Resistant Epilepsy That Target Presynaptic Transmitter Release

2014English

New Treatments for Drug-Resistant Epilepsy That Target Presynaptic Transmitter Release

2013English

A Totally New System Is Needed for Drug Research and Development

European Journal of Clinical Investigation
MedicineBiochemistryClinical Biochemistry
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy